Article
Reporting Disproportionality of Breast Cancer-Related Adverse Events Across Quinone- and Hydroquinone-Type Vitamin K Homologs in the FDA Adverse Event Reporting System
2026-05-15
Abstract excerpt
<h4>Background: </h4> /Objective: Vitamin K (VK) comprises a family of quinone compounds with potential involvement in cell death-related pathways through their redox properties. However, consistent findings have not been obtained regarding the clinical significance of VK in breast cancer (BC). Thus, we used the FDA Adverse Event Reporting System (FAERS) to examine the co-reporting patterns of BC-related adverse-e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 053d8ee7-16b7-5d94-b335-65cd49bbc4c0
- DOI
- 10.20944/preprints202605.1006.v1
